Catherine Mathis
Keine laufenden Positionen mehr
Profil
Catherine Mathis served as Director of Regulatory Affairs at Transgene SA from 1994 to 2014.
She then worked as Senior Director of Regulatory Affairs at Voisin Consulting, Inc. in 2014-2015.
In 2016, she became Vice President of Regulatory Affairs at Sangamo Therapeutics France SAS, and later that year, she became the Chief Operating Officer at ElsaLys Biotech SAS, where she worked until 2019.
Dr. Mathis holds a graduate degree from Université Paris 1 Panthéon-Sorbonne and a doctorate from Université de Paris 5 René Descartes.
Ehemalige bekannte Positionen von Catherine Mathis
| Unternehmen | Position | Ende |
|---|---|---|
| ELSALYS BIOTECH | Geschäftsführer | 01.02.2019 |
| TXCELL | General Counsel | 01.09.2016 |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | General Counsel | 01.12.2015 |
| TRANSGENE | General Counsel | 01.10.2014 |
Ausbildung von Catherine Mathis
| Université Paris 1 Panthéon-Sorbonne | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Université de Paris 5 René Descartes | Consumer Services |
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Commercial Services |
